↓ Skip to main content

Dove Medical Press

Article Metrics

Pharmacologic agents for smoking cessation: A clinical review

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, April 2010
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
69 Mendeley
Title
Pharmacologic agents for smoking cessation: A clinical review
Published in
Clinical Pharmacology : Advances and Applications, April 2010
DOI 10.2147/cpaa.s8788
Pubmed ID
Authors

Dilip Patel

Abstract

Tobacco use has been clearly demonstrated to have negative health consequences. Smoking cigarettes is the predominant method of tobacco use. The tar contained within cigarettes and other similar products is also harmful. Other tarless tobacco containing products do exist but carry no significantly decreased risk. While nicotine is considered to be principally responsible for tobacco addiction, other chemicals in the cigarette smoke including acetaldehyde may contribute to the addictive properties of tobacco products. The adverse health consequences of tobacco use have been well documented. Studies have shown that a combined behavioral and pharmacological approach is more effective in smoking cessation than either approach alone. Pharmacotherapy can achieve 50% reduction in smoking. With pharmacotherapy the estimated 6-month abstinence rate is about 20%, whereas it is about 10% without pharmacotherapy. The first-line of drugs for smoking cessation are varenicline, bupropion sustained release, and nicotine replacement drugs, which are approved for use in adults. Data are insufficient to recommend their use in adolescents. This article reviews the use of pharmacological agents used for smoking cessation. A brief overview of epidemiology, chemistry, and adverse health effects of smoking is provided.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
United States 1 1%
Unknown 67 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 14%
Researcher 9 13%
Student > Bachelor 9 13%
Student > Ph. D. Student 6 9%
Student > Doctoral Student 4 6%
Other 19 28%
Unknown 12 17%
Readers by discipline Count As %
Medicine and Dentistry 26 38%
Agricultural and Biological Sciences 9 13%
Nursing and Health Professions 3 4%
Social Sciences 3 4%
Environmental Science 3 4%
Other 9 13%
Unknown 16 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 December 2015.
All research outputs
#12,540,924
of 21,353,728 outputs
Outputs from Clinical Pharmacology : Advances and Applications
#82
of 163 outputs
Outputs of similar age
#158,318
of 303,487 outputs
Outputs of similar age from Clinical Pharmacology : Advances and Applications
#6
of 11 outputs
Altmetric has tracked 21,353,728 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 163 research outputs from this source. They receive a mean Attention Score of 4.9. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 303,487 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.